Harnessing the regenerative

Power of fat, the largest source of stem cells.

Harnessing the regenerative

Power of fat, the largest source of stem cells.

Sayenza Biosciences

Sayenza Biosciences

Sayenza Bio is a leading clinical stage biotechnology company committed to improving patient lives by harnessing the regenerative power of fat, the body’s largest source of stem cells, for limitless aesthetic and regenerative medicine applications.

At Sayenza, our passionate, doctor-driven team unites cutting-edge scientific innovation with vast commercial expertise, propelling us towards transformative breakthroughs in healthcare.

Management Team
Advisors

Our Solution

Preparation Device

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Filtration Device

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Emulsification & Micronization Device

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Mechanical Activation Device

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Problem

Time Consuming
Front Side Text Description
Back Title
Back Side Text Description
Multistep / Manual input
Front Side Text Description
Back Title
Back Side Text Description
Contamination Risk
Front Side Text Description
Back Title
Back Side Text Description
Surgeon Distraction
Front Side Text Description
Back Title
Back Side Text Description
Comparable cell counts & viability. Superior enrichment of key stem cell populations.

Traction

1st Publication

Aug
2016
$50K Grant

Aug
2016
$25K Grant

Mar
2019
PCT Filed

Jun
2020
Company Founded

Jun
2020
C18 – UCI Incubator

Jan
2021
3er place $15k

Apr
2021
Converted (US/EU)

Dec
2021
Grand Prize $25K

Apr
2022
LaunchPad Accelerator

Aug
2022
2nd Pub Published

Apr
2022
Pre-Seed $330k

Mar
2023
Provisional Patent Filed

Mar
2023

Get In Touch With Us Today

For  any inquiries or information regarding our innovative regenerative medicine  and immunotherapy technologies, please contact us through the provided form or emal.

Derek Banyard
MD, MS, MBA

Founder, CEO

Dr. Banyard is a surgeon and internationally acclaimed adipose stem cell researcher. He left plastic surgery residency to found Sayenza Biosciences and has been recognized with several grants and awards. He is former chief scientist at the Center for Tissue Engineering at UC Irvine where his early research earned him a coveted Regenerative Medicine Training grant from the California Institute for Regenerative Medicine as well as the National Endowment for Plastic Surgery grant from the Plastic Surgery Foundation. He has co-authored over 100 abstracts, posters, and publications.

Ethan Kellum
M.D.
Orthopedic Surgeon, Former Asst. Team Doctor, Boston Celtics

Dr. Kellum is owner and principal at Nashville Regenerative Orthopedics and the Kellum Stem Cell Institute. He is a sports medicine fellowshipped trained orthopedic surgeon specializing in musculoskeletal injuries and joint conditions. He is a former team doctor for the Boston Celtics and a current team doctor for USA Basketball.

Patrick Tonnard
MD, PhD
Inventor, Nanofat Technique.

Dr. Tonnard is Inventor of the revolutionary Nanofat Technique. He is co-founder at the Coupure Centre for Plastic Surgery and Aesthetic Medical Centre 2 and is also co-founder of the VZW See & Smile non-profit organization.

Alexis Verpaele
MD, PhD
Co-inventor, Nanofat Technique.

Dr. Verpaele is co-inventor of the revolutionary Nanofat Technique. He is Founder at the Coupure Centre for Plastic Surgery and Aesthetic Medical Centre 2 and is also co-founder of the VZW See & Smile non-profit organization. He is the immediate Past-President of the Royal Belgian Society for Plastic Surgery.